Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Patent
1986-05-22
1990-01-16
Draper, Garnette D.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
530412, 530416, 530417, 530820, 530825, 435 68, 435 70, C07K 1300
Patent
active
048944394
ABSTRACT:
A process is disclosed for the purification of recombinantly produced biologically active proteins in which a solution containing a mixture of materials, including the biologically active protein, is passed through a continuous porous hydrophobic membrane, and the fraction enriched in the biologically active protein is recovered. Hydrophobic proteins such as TNF and recombinant ricin toxin A chain may be purified according to the process. Conditions for enhanced recovery of purified TNF using the process are disclosed. A highly purified TNF comprising 95% or greater TNF as determined by SDS-PAGE analysis, with an endotoxin content of less than 0.1 ng/mg TNF which is substantially free of pyrogens by the USP rabbit pyrogen test at a dosage range of 1.0 to 2.4.times.10.sup.5 U/kg, is obtained.
REFERENCES:
patent: 4289690 (1981-09-01), Pestka et al.
patent: 4309418 (1982-01-01), Green
patent: 4495282 (1985-01-01), Ohnishi et al.
patent: 4677063 (1987-06-01), Mark et al.
patent: 4677064 (1987-06-01), Mark et al.
patent: 4677197 (1987-06-01), Lin et al.
Sofer et al, pi Bio/Techniques, 1983, pp. 198-201.
Bunneyear et al., Bio/Technology, 4, 1986, pp. 954-958.
Ruben et al., PNAS, 82, 1985, pp. 6637-6641.
Eur. J. Biochem 152, 1985, pp. 515-522, Marmenout et al.
Aggawal et al., JBC 260, 1985, pp. 2345-2354.
Minobe et al, J. Chromato. 248, 1982, pp. 401-408.
Bio Rad Bulletin, #1153.
Borg et al, Can. J. Physiol Pharmacol 59, 1981, pp. 890-892.
Issekutz, J. Immunol Methods 61(1983), pp. 275-281.
Pharmacia Bio Technology Products Catalog 86.
Pennica, D. et al., Nature, 312, 20/27 Dec. 1984, pp. 724-729.
Wang et al., Science (1985), 228:149-154.
Matthews, N., Br. J. Cancer (1981) 44:418.
Williamson et al., PNAS, 80, 5397-5401 (1983).
Shirai et al., Nature, 313, 803 (1985).
Abe et al., FEBS Letters 180, 203-206 (1985).
Dorin Glenn
Hanisch Wolfgang H.
Lin Leo S.
Thomson James W.
Wolfe Sidney N.
Cetus Corporation
Draper Garnette D.
Fineman Elliott L.
Giotta Gregory J.
Halluin Albert P.
LandOfFree
N-terminal derivatives of tumor necrosis factor purified by micr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-terminal derivatives of tumor necrosis factor purified by micr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-terminal derivatives of tumor necrosis factor purified by micr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1335622